| Open Document File Size: 847,52 KBShare Result on Facebook
Company Wyeth / Fort Dodge Animal Health / / Continent Europe / / Country France / Japan / United States / Italy / Canada / Australia / Portugal / Korea / Spain / Greece / / Event FDA Phase / Product Issues / Product Recall / / Facility Fort Dodge Animal Health A Division / / IndustryTerm oral products / monthly products / conventional products / fermentation product / manufacturing change / injectable products / topical applications / sustained-release product / moxidectin products / monthly oral products / similar product / manufacturing process / / MedicalCondition Allergy AERs / paralysis / disease / heartworm infection / river blindness / Heartworm Infections / 6Month Heartworm Infections / canine heartworm disease / tissue filarial nematode Onchocerca volvulus / Heartworm Disease / onchocerciasis / infection / EXECUTIVE SUMMARY Canine heartworm infection / Liver Disease / / Organization World Health Organization / U.S. Food and Drug Administration / Division of Wyeth ProHeart / Division of Wyeth / / Position EXECUTIVE / / Product ProHeart 6 / Moxidectin / US / / Technology Pharmacokinetics / Drug Metabolism / /
SocialTag |
U.S. Food and Drug Administration Notice: Archived Document The content in this document is provided on the FDA’s website for reference purposes only. It was current when produced, but is no longer maintained and may